Global Orphan Drugs Market to Grow at a CAGR of 10.20% During The Period 2017-2021.

Researchmoz added Most up-to-date research on "Global Orphan Drugs Market 2017-2021" to its huge collection of research reports. ABSTRACT About Orphan Drugs According to Orphan Drug Designation program of the US Food and Drug Administration (FDA), orphan diseases are defined as rare diseases that affects less than 2,00,000 Americans. The global orphan drugs market is expected to benefit from patent extensions like Orphan Drug Exclusivity (ODE), increasing focus of vendors on orphan drug products, and financial incentives provided by government in form of tax credits and waived FDA fees. For instance, the FDA grants a seven-year patent exclusivity to orphan drugs to treat a rare disease. Therefore, any other drug with the same indication cannot be approved by the FDA during these seven-years period. In addition, they also provide tax credits up to 50% of the total R&D cost after the drug receives the orphan drug designation. This credit can be used by the sponsor during the R&D phase of any drug irrespective of the drug designation. The orphan designated drugs are also exempted from paying the FDA fees. Thus, these financial incentives and grants for orphan drug attract many vendors to invest in developing drugs for rare diseases and make huge profits. Technavios analysts forecast the global orphan drugs market to grow at a CAGR of 10.20% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global orphan drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1059719 The market is divided into the following segments based on geography: Americas APAC EMEA Technavio's report, Global Orphan Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors AbbVie Celgene F. Hoffmann La Roche Novartis Other prominent vendors Amgen Actelion Alexion Pharmaceuticals Bayer Biogen Bristol-Myers Squibb Eli Lilly Johnson & Johnson Novo Nordisk Pfizer Sanofi Shire Teva pharmaceutical Market driver Large growth opportunities through orphan drug designation. For a full, detailed list, view our report Market challenge Costly treatment regimen results in financial burden on patients. For a full, detailed list, view our report Market trend Emerging application for orphan drug development. For a full, detailed list, view our report Key questions answered in this report What will the market size be in 2021 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction Key market highlights Pipeline analysis PART 05: Market landscape Market overview Market size and forecast Five forces analysis PART 06: Regulatory approval Orphan drug legislation PART 07: Market segmentation by product type Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-orphan-drugs-market-2017-2021-report.html/toc Biologics Non-biologics PART 08: Geographical segmentation Orphan drugs market in Americas Orphan drugs market in EMEA Orphan Drugs Market in APAC PART 09: Decision framework PART 10: Drivers and challenges Market Drivers Impact of drivers on key customer segments Market Challenges Impact of challenges on key customer segments PART 11: Market trends Emerging applications for orphan drug development Continue... About ResearchMoz ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. For More Information Kindly Contact: ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: sales@researchmoz.us Follow us on LinkedIn @ http://bit.ly/1TBmnVG Follow me on @ https://marketsizeinfo.blogspot.in/